185 related articles for article (PubMed ID: 32272131)
21. The response to nasal allergen provocation with grass pollen is reduced in patients with chronic rhinosinusitis with nasal polyposis and grass sensitization.
Calus L; Devuyst L; Van Zele T; De Ruyck N; Derycke L; Bachert C; Gevaert P
Clin Exp Allergy; 2016 Apr; 46(4):555-63. PubMed ID: 26661927
[TBL] [Abstract][Full Text] [Related]
22. Allergen-induced synthesis of interleukin-5, but not of IgE, is a key mechanism linked to symptomatic episodes of seasonal allergic rhinitis in sensitized individuals.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Masamoto T; Kato A; Washio Y; Yamada K; Hayashi M; Ohmoto Y
Scand J Immunol; 1998 Jun; 47(6):596-602. PubMed ID: 9652829
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin production pattern is allergen-specific in polysensitized patients.
Ciprandi G; De Amici M; Tosca MA; Negrini S; Puppo F; Marseglia GL
Int J Immunopathol Pharmacol; 2009; 22(3):809-17. PubMed ID: 19822071
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
25. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response.
Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M
Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115
[TBL] [Abstract][Full Text] [Related]
26. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.
Aasbjerg K; Backer V; Lund G; Holm J; Nielsen NC; Holse M; Wagtmann VR; Würtzen PA
Clin Exp Allergy; 2014 Mar; 44(3):417-28. PubMed ID: 24734285
[TBL] [Abstract][Full Text] [Related]
27. Allergy to apple cultivars among patients with birch pollinosis and oral allergy syndrome.
Wagner A; Szwed A; Buczyłko K; Wagner W
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):399-404. PubMed ID: 27593099
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis.
Asaka D; Yoshikawa M; Nakayama T; Yoshimura T; Moriyama H; Otori N
Int Arch Allergy Immunol; 2012; 158 Suppl 1():47-50. PubMed ID: 22627366
[TBL] [Abstract][Full Text] [Related]
29. [Humoral mucosal immunity in allergic rhinitis].
Kramer MF; Jordan TR; Pfrogner E; Rasp G
Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
[TBL] [Abstract][Full Text] [Related]
30. The Clinical Impact of Bet v 6 in Birch Pollen-Sensitized Patients.
Gellrich D; Eder K; San Nicoló M; Berghaus A; Gröger M
Int Arch Allergy Immunol; 2017; 173(1):34-43. PubMed ID: 28494455
[TBL] [Abstract][Full Text] [Related]
31. Seasonal increase in specific IgE in serum induced by natural Japanese cedar pollen exposure in asymptomatic and symptomatic sensitized individuals.
Kakinoki Y; Ohashi Y; Kato A; Tanaka A; Washio Y; Yamada K; Masamoto T; Nasako Y; Nakai Y; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():152-5. PubMed ID: 9879415
[TBL] [Abstract][Full Text] [Related]
32. Influence of airborne pollen counts and length of pollen season of selected allergenic plants on the concentration of sIgE antibodies on the population of Bratislava, Slovakia.
Ščevková J; Dušička J; Hrubiško M; Mičieta K
Ann Agric Environ Med; 2015; 22(3):451-5. PubMed ID: 26403113
[TBL] [Abstract][Full Text] [Related]
33. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
[TBL] [Abstract][Full Text] [Related]
34. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
35. Persistent nasal symptoms and mediator release after continuous pollen exposure in an environmental challenge chamber.
Okuma Y; Okamoto Y; Yonekura S; Iinuma T; Sakurai T; Hamasaki S; Ohki Y; Yamamoto H; Sakurai D
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):150-7. PubMed ID: 27263086
[TBL] [Abstract][Full Text] [Related]
36. Rhinitis symptoms caused by grass pollen are associated with elevated basophile allergen sensitivity and a larger grass-specific immunoglobulin E fraction.
Zidarn M; Košnik M; Silar M; Grahek A; Korošec P
Clin Exp Allergy; 2012 Jan; 42(1):49-57. PubMed ID: 22093044
[TBL] [Abstract][Full Text] [Related]
37. Distinct Gene Expression Patterns between Nasal Mucosal Cells and Blood Collected from Allergic Rhinitis Sufferers.
Watts AM; West NP; Cripps AW; Smith PK; Cox AJ
Int Arch Allergy Immunol; 2018; 177(1):29-34. PubMed ID: 29920501
[TBL] [Abstract][Full Text] [Related]
38. Effect of Lactobacillus rhamnosus GG on rBet v1 and rMal d1 specific IgA in the saliva of patients with birch pollen allergy.
Piirainen L; Haahtela S; Helin T; Korpela R; Haahtela T; Vaarala O
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):338-42. PubMed ID: 18450119
[TBL] [Abstract][Full Text] [Related]
39. Effects of airborne birch pollen levels on clinical symptoms of seasonal allergic rhinoconjunctivitis.
Caillaud D; Martin S; Segala C; Besancenot JP; Clot B; Thibaudon M;
Int Arch Allergy Immunol; 2014; 163(1):43-50. PubMed ID: 24247974
[TBL] [Abstract][Full Text] [Related]
40. Topical dsRNA challenges may induce overexpression of airway antiviral cytokines in symptomatic allergic disease. A pilot in vivo study in nasal airways.
Brandelius A; Andersson M; Uller L
Respir Med; 2014 Dec; 108(12):1816-9. PubMed ID: 25456711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
